Data protection Impressum

Technology Park

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (October 2025)

29 October 2025

The Munich- and Lausanne-based biotech secures Europe’s largest-ever Series C financing to accelerate development of next-generation antibody-drug conjugates.

Tubulis raises EUR 308 million to advance ADC therapies and expand its clinical pipeline

29 October 2025

A world-class ecosystem where research, education, and industry converge to shape the future of sustainable production.

Fribourg, Switzerland’s hub for digital manufacturing

Adaptyv raises USD 8 million to accelerate AI-powered protein validation

27 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

Western Switzerland has become a European hub for artificial intelligence, where open research, ethical standards, and technological excellence converge. Its vibrant ecosystem connects academia, industry, and international actors to advance transparent, responsible, and human-centered innovation.

Why Switzerland

Western Switzerland at the heart of artificial intelligence

With over 3,500 active organizations, AlpICT’s new map showcases the vitality and diversity of Western Switzerland’s digital landscape.

AlpICT unveils an interactive map of Western Switzerland’s IT ecosystem

7 October 2025

Switzerland Innovation has launched an interactive map to simplify access to its network of innovation parks, offering international companies and partners a clearer entry point into Switzerland’s diverse R&D landscape.

Switzerland Innovation unveils new map to strengthen international visibility of its ecosystem

29 September 2025

French robotics company Meanwhile has chosen Fribourg for its first international subsidiary, strengthening its presence in Switzerland and reinforcing its capacity to serve clients across the country.

Meanwhile opens its first international subsidiary in Fribourg

22 September 2025

A new automated platform developed by cellvie and CSEM streamlines mitochondria isolation, advancing therapeutic transplantation for ischemia-reperfusion injury.

CSEM and cellvie automate mitochondria isolation for clinical use

9 September 2025

1 2 3 4 5 6 … 22